Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab

Abstrakt

We present the first case of a successful treatment and sustained response of extensive pityriasis rubra pilaris type I with IL-23 inhibitor risankizumab.

Klíčová slova

• pityriasis rubra pilaris
• risankizumab
• biologics
• inflammatory disorders